Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities.

Journal of nanobiotechnology·2026

Same author

[Corrigendum] Effect of SDF‑1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury.

International journal of molecular medicine·2026

Same author

Genomic Insights into the Transmission Dynamics and Virulence of Carbapenem-Resistant Klebsiella pneumoniae in the ICU: A Retrospective Cohort Study.

Journal of global antimicrobial resistance·2026

Same author

A Comparison Between Two Different Directions of Landmark-Guided Femoral Vein Puncture: A Prospective Randomized Controlled Trial.

Anesthesiology research and practice·2026

Same author

Net Carbon Sink Potential of Porous Vegetated Concrete: A Life-Cycle Assessment.

Materials (Basel, Switzerland)·2026

Same author

Promoting CO<sub>2</sub> Conversion With Terminal Alkynes Over ZSM-5 Zeolite-Confined Uniform Ag Nanoparticles.

Angewandte Chemie (International ed. in English)·2026

Search research articles

Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension

Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension

Published on: June 14, 2024

Time and age dependent decrease of NT-proBNP after septal myectomy in hypertrophic obstructive cardiomyopathy.

Hao Cui¹, Xi Wu¹, Shuiyun Wang¹

¹.

Clinical Chemistry and Laboratory Medicine

|March 17, 2017

Summary

This summary is machine-generated.

Septal myectomy significantly reduces NT-proBNP levels in patients with hypertrophic obstructive cardiomyopathy. This reduction indicates positive myocardial remodeling and improved outcomes following the procedure.

Keywords:

N-terminal pro-B-type natriuretic peptide (NT-proBNP)age hypertrophic cardiomyopathy myectomy remodeling

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension

Author Spotlight: Investigating the Underlying Mechanisms of Right Ventricular Failure in Pulmonary Hypertension

Published on: June 14, 2024

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Area of Science:

Cardiology
Biomarkers
Cardiac Surgery

Background:

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a predictive factor in hypertrophic cardiomyopathy (HCM).
Left ventricular outflow tract obstruction in HCM elevates NT-proBNP levels.
Limited research exists on septal myectomy's effect on NT-proBNP in hypertrophic obstructive cardiomyopathy (HOCM).

Purpose of the Study:

To investigate the impact of septal myectomy on NT-proBNP levels in patients with HOCM.
To identify factors influencing preoperative NT-proBNP levels and the extent of postoperative decrease.

Main Methods:

Retrospective analysis of 182 HOCM patients undergoing septal myectomy.
Collection and comparison of preoperative and follow-up NT-proBNP levels.
Correlation analysis to assess factors affecting NT-proBNP levels and their reduction.

Main Results:

NT-proBNP levels significantly decreased post-myectomy (1732.4 to 816.5 pg/mL, p<0.001).
Baseline NT-proBNP correlated with gender, septal thickness, and resting pressure gradient.
NT-proBNP decrease correlated with age, baseline NT-proBNP, follow-up duration, and aortic root enlargement.

Conclusions:

Septal myectomy effectively reduces NT-proBNP levels in HOCM patients.
The time-dependent decrease in NT-proBNP suggests ongoing myocardial remodeling post-surgery.
Myectomy offers a therapeutic strategy to improve cardiac function and biomarker levels in HOCM.